Mitigation of 2,4-dinitrofluorobenzene-induced atopic dermatitis-related symptoms by Terminalia chebula Retzius

International Journal of Molecular Medicine

Volumn 28, Issue 6, 2011, Pages 1013-1018

  Nam, Dong Yoon ^a   Lee, Jin Man ^b   Heo, Jin Chul ^a,c   Lee, Sang Han ^a  

^a Kyungpook National University   (South Korea)

^b Hoseo University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Anti atopic; DNFB; IL 31; MMP 9; T bet; Terminalia chebula retzius

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; GELATINASE B; INTERLEUKIN 31; TERMINALIA CHEBULA EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; ECZEMA; EOSINOPHIL; IMMUNE RESPONSE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWELLING; TERMINALIA CHEBULA;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DERMATITIS, ATOPIC; DINITROFLUOROBENZENE; EOSINE YELLOWISH-(YS); EOSINOPHILS; HEMATOXYLIN; INTERLEUKINS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS; SKIN; T-BOX DOMAIN PROTEINS; TERMINALIA;

EID: 80053511580     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.792     Document Type: Article

References (40)

1. Ahmad I, Mehmood Z and Mohammad F: Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol 62: 183-193, 2008.
2. Holst B and Williamson G: Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol 19: 73-82, 2008.
3. Srikumar R, Parthasarathy NJ, Shankar EM, Manikandan S, Vijayakumar R. Thangaraj R, Vijayananth K, Sheeladevi R and Rao UA: Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV-infected patients. Phytother Res 21: 476-480, 2007. (Pubitemid 46715091)
4. Cheng HY, Lin TC, Yu KH, Yang CM and Lin CC: Antioxidant and free radical scavenging activities of Terminalia chebula. Biol Pharm Bull 26: 1331-1335, 2003.
5. Lee HS, Jung SH, Yun BS and Lee KW: Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol 81: 211-218, 2007.
6. Na M, Bae K, Kang SS, Min BS, Yoo JK, Kamiryo Y, Senoo Y, Yokoo S and Miwa N: Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Terminalia chebula fruit. Phytother Res 18: 737-741, 2004. (Pubitemid 39481693)
7. Naik GH, Priyadarsini KI, Naik DB, Gangabhagirathi R and Mohan H: Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector. Phytomedicine 11: 530-538, 2004. (Pubitemid 39312630)
8. Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM and Mohan H: In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res 19: 582-586, 2005. (Pubitemid 41375239)
9. Kim HG, Cho JH, Jeong EY, Lim JH, Lee SH and Lee HS: Growth-inhibiting activity of active component isolated from Terminalia chebula fruits against intestinal bacteria. J Food Prot 69: 2205-2209, 2006. (Pubitemid 44497027)
10. Malekzadeh F, Ehsanifar H, Shahamat M, Levin M and Colwell RR: Antibacterial activity of black myrobalan (Terminalia chebula Retz.) against Helicobacter pylori. Int J Antimicrob Agents 18: 85-88, 2001. (Pubitemid 32703873)
11. Ahn MJ, Kim CY, Lee JS, Kim TG, Kim SH, Lee CK, Lee BB, Shin CG, Huh H and Kim J: Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med 68: 457-459, 2002. (Pubitemid 34606693)
12. Vonshak A, Barazani O, Sathiyamoorthy P, Shalev R, Vardy D and Golan-Goldhirsh A: Screening South Indian medicinal plants for antifungal activity against cutaneous pathogens. Phytother Res 17: 1123-1125, 2003. (Pubitemid 37351595)
13. Prasad L, Husain KT, Jahangir T and Sultana S: Chemomodulatory effects of Terminalia chebula against nickel chloride induced oxidative stress and tumor promotion response in male Wistar rats. J Trace Elem Med Biol 20: 233-239, 2006. (Pubitemid 44708718)
14. Srikumar R, Parthasarathy NJ, Manikandan S, Narayanan GS and Sheeladevi R: Effect of Triphala on oxidative stress and on cellmediated immune response against noise stress in rats. Mol Cell Biochem 283: 67-74, 2006.
15. Lee HS, Won NH, Kim KH, Lee H, Jun W and Lee KW: Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol Pharm Bull 28: 1639-1644, 2005. (Pubitemid 41324124)
16. Harper JI, Godwin H, Green A, Wilkes LE, Holden NJ, Moffatt M, Cookson WO, Layton G and Chandler S: A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis. Br J Dermatol 162: 397-403, 2010.
17. Boguniewicz M and Leung DY: Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 125: 4-13, 2010.
18. Hanifin JM: Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol 129: 320-322, 2009.
19. Kähäri VM and Saarialho-Kere U: Matrix metalloproteinases in skin. Exp Dermatol 6: 199-213, 1997.
20. Heo JC, Woo SU, Kweon MA, Park JY, Lee HK, Son M, Rho JR and Lee SH: Aqueous extract of the Helianthus annuus seed alleviates asthmatic symptoms in vivo. Int J Mol Med 21: 57-61, 2008. (Pubitemid 351222868)
21. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.
22. Lee SH: An extract from Terminalia chebula Retzius for prophylaxis or treatment to dermatitis and a pharmaceutical composition comprising the same as an effective component. Korea Patent Application 10-2010-0028242, pp1-21, 2010.
23. Inagaki N, Shiraishi N, Igeta K, Itoh T, Chikumoto T, Nagao M, Kim JF and Nagai H: Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol 546: 189-196, 2006. (Pubitemid 44331846)
24. Parks WC, Wilson CL and López-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629, 2004. (Pubitemid 39025047)
25. Kim DY, Ryu SY, Lim JE, Lee YS and Ro JY: Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 557: 76-86, 2007. (Pubitemid 46135553)
26. Kim D, Kim SH, Park EJ, Kang CY, Cho SH and Kim S: Anti-allergic effects of PG102, a water-soluble extract prepared from Actinidia arguta, in a murine ovalbumin-induced asthma model. Clin Exp Allergy 39: 280-289, 2009.
27. Jeon JH, Kwon SC, Park D, Shin S, Jeong JH, Park SY, Hwang SY, Kim YB and Joo SS: Anti-allergic effects of white rose petal extract and anti-atopic properties of its hexane fraction. Arch Pharm Res 32: 823-830, 2009.
28. Nakano N, Nishiyama C, Tokura T, Nagasako-Akazome Y, Ohtake Y, Okumura K and Ogawa H: Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation. Int Arch Allergy Immunol 147: 213-221, 2008.
29. Shinomiya F, Hamauzu Y and Kawahara T: Anti-allergic effect of a hot-water extract of quince (Cydonia oblonga). Biosci Biotechnol Biochem 73: 1773-1778, 2009.
30. Devillers A, Van Toorenenbergen AW, Klein-Heerenbrink GJ, Muldert PG and Oranje AP: Elevated levels of plasma matrix metalloproteinases-9 in patients with atopic dermatitis: a pilot study. Clin Exp Dermatol 32: 311-313, 2007. (Pubitemid 46495803)
31. Belleguic C, Corbel M, Germain N, Lena H, Boichot E, Delaval PH and Lagente V: Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 32: 217-223, 2002. (Pubitemid 34429599)
32. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J and Gross JA: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5: 752-760, 2004. (Pubitemid 39023308)
33. Takaoka A, Arai I, Sugimoto M, Yamaguchi A, Tanaka M and Nakaike S: Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 516: 180-181, 2005. (Pubitemid 40799355)
34. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Grønhøj-Larsen C and Matsushima K: Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 18: 35-43, 2009.
35. Raap U, Wichmann K, Bruder M, Ständer S, Wedi B, Kapp A and Werfel T: Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122: 421-423, 2008.
36. Lametschwandtner G, Biedermann T, Schwärzler C, Günther C, Kund J, Fassl S, Hinteregger S, Carballido-Perrig N, Szabo SJ, Glimcher LH and Carballido JM: Sustained T-bet expression confers polarized human Th2 cells with Th1-like cytokine production and migratory capacities. J Allergy Clin Immunol 113: 987-994, 2004. (Pubitemid 38608612)
37. Szabo SJ, Kim ST, Costa GL, Zhang XC, Fathman G and Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669, 2000.
38. Heo JC, Rho JR, Kim TH, Kim SY and Lee SH: An aqueous extract of green tea Camellia sinensis increases expression of Th1 cell-specific anti-asthmatic markers. Int J Mol Med 22: 763-767, 2008.
39. Heo JC, Park CH, Lee HJ, Kim SO, Kim TH and Lee SH: Amelioration of asthmatic inflammation by an aqueous extract of Spinacia oleracea Linn. Int J Mol Med 25: 409-414, 2010.
40. Gao H, Huang YN, Gao B and Kawabata J: Chebulagic acid is a potent alpha-glucosidase inhibitor. Biosci Biotechnol Biochem 72: 601-603, 2008. (Pubitemid 351353679)